China Halts Imports Of Pfizer Inc.'s Diflucan On Paperwork Glitch

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

China suspended imports of U.S. drugmaker Pfizer Inc's AIDS-related drug Diflucan on Tuesday, citing a problem with late paperwork, the country's food and drug watchdog said in a statement on its website. Pfizer, the largest drugmaker in the United States, contravened Chinese law when one of its France-based factories failed to submit a supplementary application on time, the China Food and Drug Administration (FDA) said in the statement. With the country's healthcare spending forecast to nearly triple to $1 trillion by 2020 from $357 billion in 2011, according to consulting firm McKinsey, China is a magnet for makers of medicines and medical equipment.

Help employers find you! Check out all the jobs and post your resume.

Back to news